Derma Sciences Earnings Preview: Get Ahead of the Analysts

Derma Sciences (NASDAQ:DSCI) will report earnings before markets open on Monday, April 1st. Derma Sciences, Inc. markets and sells a range of skin care, wound management, and specialty securement devices. The Company’s products are used primarily in hospitals, nursing homes, and home health settings. Derma’s products include wound dressings, moisturizing lotions, hand soaps, incontinence care products, disinfectants, wound closure strips, and catheter/tubing securement devices.

Here is your Cheat Sheet to Derma Sciences Earnings:

Earnings Expectations: Analysts expect earnings of $-0.31 per share on revenues of $19.73 million.

Analyst Trends:

Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a loss of $0.36 and has not changed. For the current year, the average estimate is a loss of $1.02, which is the same as the estimate ninety days ago.

Earnings Trends:

Here’s how Derma Sciences has been performing on an annual basis:

Fiscal Year 2007 2008 2009 2010 2011
Revenue ($) in millions 34.14 50.20 48.53 56.47 62.63
Diluted EPS ($) -0.72 -0.82 -0.25 -0.39 -0.49

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Sep. 30, 2011 Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012
Revenue ($) in millions 15.85 16.53 15.28 17.61 19.65
Diluted EPS ($) -0.08 -0.26 -0.24 -0.23 -0.24

Past Performance:
Derma Sciences has beat analyst estimates 1 time in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]